The following general aspects should be considered:
- An individualised, patient-centred approach for diagnosis and treatment of pain is essential to establish a therapeutic alliance between patient and clinician.
- Consider patient variables that may affect opioid dose in patients prior to opioid use.1
- In patients with acute pain e.g. post-surgery pain, the use of medication should be for the shortest necessary time.1
- All patients should be carefully selected, abuse risk factors evaluated and regular monitoring and follow-up implemented to ensure that opioids are used appropriately3,4 and in alignment with treatment goals (pain intensity and functionality) as agreed with the patient.3,4
- Patients should be made aware of the potential side effects of opioids and the potential of developing tolerance, dependence and addiction.3,4
- It is important to optimally use multimodal, non-opioid approaches in acute and chronic pain before escalating to opioids or in conjunction with opioid therapy.1
- Addiction is possible even when opioids are taken as directed. The exact prevalence of abuse in patients treated with opioids for chronic pain is difficult to determine.5
- Regular clinical reviews are required for long-term opioid treatment to assess pain control, impact on lifestyle, physical and psychological wellbeing, side effects and continued need for treatment2
- Any long term treatment with opioids should be monitored and re-evaluated regularly, including tapering down the dose or discontinuing treatment3,4
- Signs of opioid use disorder should be monitored and addressed3,4
- Patients and the general public can benefit from clear educational materials and awareness interventions to support the responsible use of opioids.6
References
1.DHHS Pain Management Best Practices Inter-Agency Taskforce Report May 2019.
2.O’Brien T et al. Eur J Pain 2017;21:3-192.
3.Faculty of Pain Medicine, Opioids Aware. Available at: https://www.rcoa.ac.uk/faculty-of-pain-medicine/opioids-aware (accessed September 2019).
4.Kosten TR et al, Scie Pract. Perspect 2002;1:13-20.
5.Rosenblum A et al Exp. Clin. Psychopharmacol. 2008;16(5):405-416.
6.OECD Health Policy. Addressing Problematic opioid use in OECD Countries May 2019. Available at: http://www.oecd.org/health/addressing-problematic-opioid-use-in-oecd-countries-a18286f0-en.htm (accessed January 2020).
M-N/A-UK-01-24-0011 - February 2024